Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig. 5H).”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [123]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Molecular tectonics in biomineralization and biomimetic materials chemistry
Mann, S. (1993) · Nature · doi:10.1038/365499a0 · Cited by 1,165
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Research works printed but not linked: 1
- Schwechheimer C., 2015, Nat. Rev. Immunol., 13, 605
Cited by
Items 301–333 of 333
Applications of Uniform Particles for Targeted Delivery of Anticancer Drugs
Ma, G. (2023) · Wiley eBooks · doi:10.1002/9783527830855.ch7
Self-citationKanser Tedavisinde Bakteri Destekli İlaç Taşıyıcı Sistemler
ÖZTÜRK, M., & Pehlivan, S. B. (2024) · Hacettepe University Journal of the Faculty of Pharmacy · doi:10.52794/hujpharm.1392635
Ding, N., Yu, Q., Cui, S., Su, Z., Han, Y., Zhou, Z., Sun, S., Hong, H., & Yang, D. (2026) · Nanoscale Horizons · doi:10.1039/d6nh00034g
n‐Butanol Enables OMVs as Heat‐Responsive Nanometer Ultrasound Contrast Agents for Tumor Imaging
Wang, L., Yang, S., Zhou, T. Y., Yang, S., Bi, P., Zhou, J., Wang, Q., & Qiao, H. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202505161
Ma, J., Xie, Y., Jiang, L., Liang, X., & Liu, G. (2025) · Springer eBooks · doi:10.1007/978-3-031-93425-4_13
Zheng, B., Li, F., Chen, J., Yan, Q., Deng, R., Li, Z., Ruan, J., & Li, X. (2025) · Nano Research · doi:10.26599/nr.2025.94908262
Self-citationShen, M., Guo, L., Zhang, H., Zheng, B., Liu, X., Gu, J., Yang, T., Sun, C., & Yi, X. (2024) · Figshare · doi:10.6084/m9.figshare.25963103
Chen, S., He, Y., Huang, X., Shen, Y., Zou, Q., Yang, G., Fu, L., Liu, Q., & Luo, D. (2024) · Figshare · doi:10.6084/m9.figshare.26736444
Wang, J., Liang, S., Chen, S., Ma, T., Chen, M., Niu, C., Leng, Y., & Wang, L. (2024) · Figshare · doi:10.6084/m9.figshare.26011817
Self-citationChen, S., He, Y., Huang, X., Shen, Y., Zou, Q., Yang, G., Fu, L., Liu, Q., & Luo, D. (2024) · Figshare · doi:10.6084/m9.figshare.26736441
Mou, Z., Zhang, Y., He, X., Zhang, M., He, X., Wang, W., Liu, Z., Xiong, X., Ma, P., & Yu, K. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100510 · Cited by 1
“…nonprobiotic bacterial strains may induce inflammatory responses, hemolysis and organ damage, including hepatic/renal injury and spleno-megaly, potentially because of their LPS content or transport of bioactive molecules (Zhuang et al., 2021; Noh et al., 2023; Li et al., 2020; Qing et al., 2020).”
Wu, J., Li, J., Wang, M., Ma, P., Liu, H., Lin, J., Yan, F., & Huang, P. (2026) · Nano Research · doi:10.26599/nr.2026.94908589
Frontiers in bacterial outer membrane vesicles: From basic characteristics to cancer therapy
Ma, S., Jianxuan, S., Jingyu, X., Ye, A., Jinzhou, X., Shaogang, W., & Xia, Q.-D. (2026) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2026.01.07
Liu, Y., Cai, Q., Hu, X., Liu, X., Guo, P., Zhang, Y., Liu, H., Wang, W., Zheng, D., Pan, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.14.711758
Self-citationWang, J., Zhu, G., Zhang, H., Zeng, L., Li, D., Li, X., Yu, Y., Liang, L., Zhang, L., & Yu, L. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100537
“…of this study include unvalidated CD8 + T cell cytotoxicity, undetectable levels of key cytokines (IL-12, IFN-γ ) and cytotoxic markers (granzyme B, perforin), and insufficient molecular validation of the TLR pathway due to experimental constraints (Ribas and Wolchok, 2018; Qing et al., 2020).”
Self-citationSharif, E., Nematollahi, L., & Mohit, E. (2026) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-026-05646-5
“Moreover, they observed no clear sign of metastasis in folic acid modified OMV@CaP (OMV@CaP-FAs)-treated mice [51].”
Qin, J., He, Y., Yang, Y., Yang, J., Liu, Z., Xie, Y., Lu, W., Liu, M., Zhao, Z., Cai, D., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1819923 · Cited by 2
Chen, X., Qi, H., Qiu, F., Yang, B., Wei, Y., Hu, H., Liu, P., Zou, T., Gong, P., Ji, T., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103184
“The presence of acidic amino acid residues on the FOBs surface provides “ nucleation sites ” for Ca 2 + coordination, thereby facilitating CaP deposition and formation of a stable core-shell Cur/FOBs@CaP structure [34,35].”
Hadjigol, S., Shah, B. A., Yazdani, N., & O’brien-simpson, N. M. (2026) · Cells · doi:10.3390/cells15100855
“For instance, OMVs can be decorated with targeting ligands like Arginylglycylaspartic acid (RGD) peptides or conjugated with molecules like calcium phosphate for specific applications [340].”
Vaccine adjuvant design: multidimensional regulation from immune activation to immune programming
Fu, K., Cao, Y., Ma, X., & Zhang, Y. (2026) · Scientia Sinica Vitae · doi:10.1360/ssv-2026-0089
Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology
Liu, X., Zhang, H., Du, R., Liu, Z., Ren, Y., & Yang, X. S. (2026) · Cancer Biology & Therapy · doi:10.1080/15384047.2026.2683171 · Cited by 1
“103 Similarly, Chen et al. developed Shewanella MR-1-based phototropic bacteria ( PTBs ) encapsulating methylene blue (MB), which inhibited mitochondrial function and suppressed heat shock protein (HSP) expression to potentiate PTT. 104 To address thermal resistance, Wang et al. designed thermally…”
Liu, J., Fu, C., Wu, Q., Kan, J., Cui, Z., Dong, R., Zheng, Z., Kong, Y., Zhang, Y. Y., Liu, L. F., et al. (2026) · MedMat. · doi:10.1097/mm9.0000000000000049
Engineered Bacterial Outer Membrane Vesicles for Tumor Diagnosis and Treatment: A Review
Xue, W.-C., Zhuang, W., Liu, P., & Xie, H. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c01746
Wu, D., Zhou, J., Cao, Y., Ping, K., Zhao, B., Yang, Y., Yu, C., Yu, X., & Qi, S. (2026) · Advanced Science · doi:10.1002/advs.76664
“While Ca 2 + -based biomineralizations have been explored for tumor microenvironment-responsive release, single-ion therapy is hampered by brief systemic circulation, dose-dependent systemic toxicity and inefficiency pyroptosis induction [ 6, 7 ].”
Ying, H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1806945
Programmable three‐state nanoreactor for spatiotemporally controlled tumor therapy
Lu, G., Ye, P., Li, X., Ma, K., Lyu, C., Zhang, K., Luo, R., Ji, Y., Mei, S., Zhang, F., et al. (2026) · BMEMat · doi:10.1002/bmm2.70098
Self-citationArming the living drugs: nanoengineered bacteria for precision tumor theranostics
Yu, Y., Yang, W., & Zhang, B. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04888-z
Role of bacterial outer membrane vesicles in immune evasion during infection
鄢柏山, Chen, S., Wan, J., Huang, X., Jia, Z., Zhou, C., & Ma, L. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05179-9
“Qing et al. (2020) found that OMVs derived from Escherichia coli could reprogram the tumor microenvironment by downregulating Treg and M2 macrophages and increasing CD8 + T cell infiltration.”
Khaneshi, M., Akhijahani, R. F., Mobayen, G., Shadravan, S., & Lahouty, M. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2735996
Harnessing bacterial extracellular vesicles for bone and cartilage organoids
Liu, H., Lv, X., Cheng, T., Yan, L., Lai, Y., Guo, K., Jing, Y., Shen, H., & Su, J. (2026) · BMEMat · doi:10.1002/bmm2.70140
Gut Microbiota-Derived Extracellular Vesicles in Cancer: Friends or Foes?
Selim, H. M. R. M., Abdallah, D. M., El-Gazar, A. A., Abo-Zalam, H. B., Ragab, G. M., El-Gazar, R. A., Ali‐Tammam, M., & El-Abhar, H. S. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11227-z
An update on combinational chemo-immunotherapy for breast cancer using nanotechnology
Saraf, S., Tiwari, A., Kumari, P., Gautam, L., & Jain, S. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2749964
Metadata
- Authors
- Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., Wei, W., & Ma, G.
- Affiliations
- Chinese Academy of Sciences (CN)
- State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Biotechnology No. 20 Dongda Street Beijing 100071 P. R. China
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wei, Wei
- Ma, Guanghui
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 47
- Pages
- e2002085-e2002085
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3090405704
- Cited by
- 309
- References
- 48
- Citations by year
- 2026: 31 · 2025: 72 · 2024: 75 · 2023: 56 · 2022: 42 · 2021: 31 · 2020: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (21821005)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- bacterial outer membrane vesicles, biomineralization, tumor microenvironment reprogramming, immunosuppression, M2 to M1 macrophage polarization, pH-responsive drug delivery, folic acid, photosensitizers, combination therapy, intravenous injection
- MeSH terms
- Extracellular Vesicles, Biomineralization, Bacterial Outer Membrane, Adjuvants, Immunologic, Immunotherapy, Macrophages, Safety, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.